Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 153 participants.
Also called NCT07049120
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 153 participants
- Registry
-
NCT07049120
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07049120. Allocation not applicable; no masking; primary purpose prevention. Start 2025-06-30 (anticipated); primary completion 2027-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- ZENFLEX Pro™ Peripheral Drug-eluting Stent System
- Lead sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
Record details
- Record id
cardio:ct-nct07049120- Content hash
72fc352941c32817367c1ab670ce1cef72f7b489fe3cdcc7180fcbb7c16eba7a